| Product Code: ETC12838630 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The import shipments of influenza medications to Grenada in 2024 were primarily sourced from the USA, Barbados, UK, India, and Turkey. Despite a decrease in the Compound Annual Growth Rate (CAGR) over the period 2020-2024, the market concentration remained high, indicating a reliance on these key exporting countries. The significant decline in the growth rate from 2023 to 2024 suggests a challenging market environment or potential shifts in demand. Grenada`s import of influenza medications continues to be influenced by these key exporting countries, emphasizing the importance of monitoring market dynamics and diversifying sources.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Grenada Influenza Medications Market Overview |
3.1 Grenada Country Macro Economic Indicators |
3.2 Grenada Influenza Medications Market Revenues & Volume, 2021 & 2031F |
3.3 Grenada Influenza Medications Market - Industry Life Cycle |
3.4 Grenada Influenza Medications Market - Porter's Five Forces |
3.5 Grenada Influenza Medications Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Grenada Influenza Medications Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Grenada Influenza Medications Market Revenues & Volume Share, By Patient Age Group, 2021 & 2031F |
4 Grenada Influenza Medications Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of influenza cases in Grenada |
4.2.2 Growing awareness about the importance of influenza vaccination |
4.2.3 Government initiatives to promote influenza prevention and control |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in remote areas of Grenada |
4.3.2 High cost of influenza medications |
4.3.3 Lack of awareness about the available influenza treatment options |
5 Grenada Influenza Medications Market Trends |
6 Grenada Influenza Medications Market, By Types |
6.1 Grenada Influenza Medications Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Grenada Influenza Medications Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 Grenada Influenza Medications Market Revenues & Volume, By Antiviral Drugs (Oseltamivir, Zanamivir, Peramivir, Baloxavir), 2021 - 2031F |
6.1.4 Grenada Influenza Medications Market Revenues & Volume, By Symptom Relief Medications (Pain Relievers, Decongestants, Antihistamines), 2021 - 2031F |
6.2 Grenada Influenza Medications Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Grenada Influenza Medications Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 Grenada Influenza Medications Market Revenues & Volume, By Intravenous (IV), 2021 - 2031F |
6.2.4 Grenada Influenza Medications Market Revenues & Volume, By Inhalation, 2021 - 2031F |
6.3 Grenada Influenza Medications Market, By Patient Age Group |
6.3.1 Overview and Analysis |
6.3.2 Grenada Influenza Medications Market Revenues & Volume, By Pediatric, 2021 - 2031F |
6.3.3 Grenada Influenza Medications Market Revenues & Volume, By Adult, 2021 - 2031F |
6.3.4 Grenada Influenza Medications Market Revenues & Volume, By Geriatric, 2021 - 2031F |
7 Grenada Influenza Medications Market Import-Export Trade Statistics |
7.1 Grenada Influenza Medications Market Export to Major Countries |
7.2 Grenada Influenza Medications Market Imports from Major Countries |
8 Grenada Influenza Medications Market Key Performance Indicators |
8.1 Percentage of population vaccinated against influenza |
8.2 Number of healthcare facilities offering influenza medications |
8.3 Rate of influenza cases reported annually in Grenada |
9 Grenada Influenza Medications Market - Opportunity Assessment |
9.1 Grenada Influenza Medications Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Grenada Influenza Medications Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Grenada Influenza Medications Market Opportunity Assessment, By Patient Age Group, 2021 & 2031F |
10 Grenada Influenza Medications Market - Competitive Landscape |
10.1 Grenada Influenza Medications Market Revenue Share, By Companies, 2024 |
10.2 Grenada Influenza Medications Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here